Scotch Corner IPO: What You Should Know Key Project Information Overview

X-twitter Linkedin Facebook-f Vimeo

Smith & Nephew to announce Q3 trading report on 26 April 2023

Smith & Nephew plc

Smith & Nephew plc (LON:SN, NYSE: SNN), the global medical technology business, will announce its trading report for the first quarter ended Saturday, 1 April 2023 on Wednesday, 26 April 2023 at 7.00am BST / 2.00am EDT.

This will be followed by a conference call for financial analysts, at 8.30am BST / 3.30am EDT, details of which will be published on the Smith & Nephew website at https://www.smith-nephew.com/en/about-us/investors#quarterly-reporting.

Share on:
Preferred Source

Latest Company News

Smith & Nephew plc

Smith & Nephew reports steady Q1 growth and confirms 2026 outlook

Underlying revenue grew 3.1% in Q1, supported by innovation and strong Sports Medicine performance. The company maintains its full-year targets and unveils a new $500m buyback program.
Smith & Nephew plc

Smith & Nephew to host Surgeon Insights event in London

Smith & Nephew will host an investor event in London featuring US surgeons discussing innovation platforms across sports medicine, wound care, and orthopaedics, with presentations and Q&A sessions led by company leadership.
Smith & Nephew plc

Smith & Nephew delivers higher profits and cash generation in 2025

Smith+Nephew reported full-year 2025 revenue of $6.16 billion, up 6.1% on a reported basis, with trading profit rising 15.5% and free cash flow increasing 52.5%.
Smith & Nephew plc

Smith & Nephew outlines RISE strategy with upgraded guidance and new 2028 financial targets

Smith & Nephew has introduced its RISE strategy at its Capital Markets Day, setting out 2028 targets for stronger revenue growth, higher profit and increased free cash flow.
Smith & Nephew plc

Smith & Nephew to host Capital Markets Days in London and New York

Smith & Nephew will hold Capital Markets Days on 8 December in London and 11 December in New York to outline its new strategy, mid-term priorities, and portfolio growth plans.
Smith & Nephew plc

Smith & Nephew Plc delivers strong H1 with profit up 31%

Smith+Nephew reported 5.0% underlying revenue growth and a 30.6% rise in operating profit for H1 2025. EPS rose 36.6% to 33.5¢ and free cash flow surged to $244m. The company also announced a $500m share buyback for H2, supported by strong cash generation and margin expansion.

    Latest interviews

    View all interviews 

    Company Presentations

    View all Company Presentations

    BrokersTalk

    View all Broker Talk

    FTSE 100 News

    Search

    Green News

    View all Sustainable sectors, Plcs and news  

    Q&A's

    View all Question and Answers

    Funds

    View all Funds, Market Insights and news

    UK Broker Ratings

    Hardman & Co

    Don't Miss Our News Alerts

    Subscribe Free

    Find us on:

    Linkedin Facebook

    Follow us on Social Media:

    Home X-twitter Linkedin Facebook Spotify Apple